SkyAI, Inc. reported significant financial challenges in its latest 10-Q filing for the second quarter of 2026, revealing a net loss of $23.3 million for the three months ending June 30, compared to a net income of $3.6 million during the same period in 2025. For the first half of 2026, the company recorded a net loss of $109.5 million, a stark contrast to a profit of $5.5 million in the first half of 2025. The company's revenue for the second quarter was $2.3 million, primarily from staking activities, while total revenue for the first half was $5.5 million, indicating a shift in business focus.
The financial performance reflects a substantial decline in revenue and an increase in operating expenses, which totaled $25.4 million for the second quarter, compared to $1.4 million in the same quarter of the previous year. The increase in expenses was driven by consulting fees, research and development costs, and significant unrealized losses on digital commodities, which amounted to $13.5 million in the second quarter alone. The company’s accumulated deficit has now reached $426.5 million, up from $316.9 million at the end of 2025.
Strategically, SkyAI has undergone a transformation, shifting from its legacy medical device operations to focus on a technology-driven financial platform. This change was formalized with a name change to SkyAI, Inc. and a new trading symbol on the stock exchange. The company has also established an international operational headquarters in Hong Kong, reflecting its commitment to expanding its digital commodity treasury strategy, particularly in accumulating Solana (SOL), a digital asset.
Operationally, SkyAI's total current assets decreased to $15.5 million as of June 30, 2026, down from $18.9 million at the end of 2025. The company reported a significant drop in accounts receivable from digital currency, which fell to $240,121 from $507,842. The total liabilities also decreased to $3.1 million, down from $4.7 million, primarily due to the repayment of a margin loan. The company’s employee headcount remains stable, but the focus on digital commodities has led to a reevaluation of its operational metrics.
Looking ahead, SkyAI's management has indicated that the company is committed to its new strategic direction, emphasizing the development of its financial technology platform and digital asset management. However, the significant losses and operational shifts raise questions about the sustainability of its business model in the competitive digital asset landscape. The company has not provided specific guidance on future revenue expectations, but it remains focused on leveraging its digital commodity strategy to drive growth.
About SkyAI, Inc.
Sharps Technology, Inc. develops innovative medical device and pharmaceutical packaging solutions, primarily focusing on safety syringes and prefillable syringe systems. Its core products include ultra-low waste, safety-enhanced disposable syringes and polymer-based prefillable syringes for global healthcare markets. The company emphasizes safety, product performance, and regulatory compliance, serving healthcare providers, pharmaceutical companies, and international markets with a competitive edge in drug delivery technology.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov